Research Article
Comparison of Reverse Transcription Quantitative Real-Time PCR, Flow Cytometry, and Immunohistochemistry for Detection of Monoclonality in Lymphomas
Table 1
Detailed patient information.
| Sample ID | Classification | Gender | Age | FC | IHC | RT-qPCR |
| 111 | CLL | F | 70 | ND | Lambda | Lambda | 112 | CLL | F | 82 | ND | Lambda | MNP | 113 | CLL | M | 58 | Lambda | Lambda | Lambda | 115 | CLL | F | 61 | Lambda | Lambda | Lambda | 116 | CLL | F | 57 | Kappa | Kappa | Kappa | 117 | CLL | F | 75 | Kappa | Kappa | Kappa | 118 | CLL | F | 85 | Kappa | Kappa | Kappa | 119 | CLL | F | 48 | ND | Lambda | Lambda | 131 | CLL | M | 72 | ND | Lambda | Lambda | 132 | CLL | F | 59 | ND | Lambda | Lambda | 145 | CLL | F | 76 | Kappa | Kappa | MNP | 146 | CLL | M | 46 | Lambda | Lambda | Lambda | 147 | CLL | F | 74 | Kappa | Kappa | Kappa | 149 | CLL | F | 76 | Kappa | Kappa | MNP | 189 | CLL | F | 65 | Kappa | Kappa | MNP | 191 | CLL | M | 60 | Lambda | Lambda | Lambda | 120 | DLBL | M | 80 | ND | Kappa | MNP | 121 | DLBL | M | 81 | ND | Kappa | Kappa | 123 | DLBL | M | 64 | Kappa | Kappa | Kappa | 124 | DLBL | F | 77 | Kappa | Kappa | Kappa | 125 | DLBL | M | 57 | ND | MNP | Lambda | 126 | DLBL | M | 70 | Lambda | Lambda | Lambda | 127 | DLBL | M | 70 | Kappa | Kappa | Kappa | 129 | DLBL | M | 58 | ND | Kappa | MNP | 133 | DLBL | M | 72 | MNP | Lambda | MNP | 135 | DLBL | F | 75 | MNP | Kappa | Kappa | 136 | DLBL | F | 78 | ND | Kappa | MNP | 137 | DLBL | M | 70 | Kappa | Kappa | Kappa | 138 | DLBL | M | 72 | ND | Kappa | MNP | 139 | DLBL | M | 33 | Kappa | Kappa | Kappa | 140 | DLBL | F | 78 | Kappa | Kappa | kappa | 153 | DLBL | M | 19 | ND | Kappa | Kappa | 156 | DLBL | M | 58 | Kappa | Kappa | Kappa | 182 | DLBL | F | 75 | MNP | Kappa | MNP | 184 | DLBL | M | 55 | Kappa | Kappa | Kappa | 186 | DLBL | F | 66 | Kappa | Kappa | Kappa | 157 | FL | F | 54 | Kappa | Kappa | MNP | 158 | FL | F | 51 | ND | Kappa | MNP | 159 | FL | M | 77 | ND | Kappa | MNP | 160 | FL | F | 60 | ND | Lambda | MNP | 161 | FL | M | 70 | Lambda | Lambda | MNP | 162 | FL | M | 69 | Kappa | Kappa | Kappa | 163 | FL | M | 52 | Kappa | Kappa | Kappa | 164 | FL | M | 53 | ND | Kappa | Kappa | 165 | FL | F | 59 | Kappa | Kappa | MNP | 166 | FL | M | 61 | MNP | Kappa | MNP | 167 | FL | F | 30 | MNP | Lambda | MNP | 168 | FL | M | 51 | MNP | Kappa | Kappa | 208 | FL | F | 83 | MNP | ND | MNP | 209 | FL | F | 55 | Lambda | Lambda | Lambda | 210 | FL | F | 46 | MNP | Kappa | MNP | 211 | FL | M | 64 | Lambda | ND | MNP | 204 | MCL | M | 61 | Lambda | Lambda | Lambda | 206 | MCL | F | 78 | Kappa | Kappa | Kappa | 207 | MCL | F | 70 | Kappa | Kappa | MNP | 101 | LA | F | 62 | ND | MNP | Control | 102 | LA | M | 25 | ND | MNP | Control | 103 | LA | M | 25 | ND | MNP | Control | 104 | LA | M | 16 | ND | MNP | Control | 105 | LA | F | 58 | ND | MNP | Control | 106 | LA | M | 59 | ND | MNP | Control | 107 | LA | M | 41 | ND | MNP | Control | 108 | LA | M | 7 | ND | MNP | Control | 109 | LA | F | 33 | ND | MNP | Control | 110 | LA | F | 28 | ND | MNP | Control | 192 | LA | F | 1 | MNP | MNP | Control | 193 | LA | F | 40 | MNP | MNP | Control | 194 | LA | M | 28 | MNP | MNP | Control | 195 | LA | M | 20 | MNP | MNP | Control | 196 | LA | M | 13 | MNP | MNP | Control | 197 | LA | M | 30 | MNP | MNP | Control | 198 | LA | F | 10 | MNP | MNP | Control | 199 | LA | F | 58 | MNP | MNP | Control | 200 | LA | M | 49 | MNP | MNP | Control | 201 | LA | F | 57 | MNP | MNP | Control |
|
|
CLL: chronic lymphocytic leukemia; DLBL: diffuse large B cell lymphoma; FL: follicular lymphoma; LA: lymphadenitis; F: female; M: male; MNP: monoclonality not proven; FC: flow cytometry; IHC: immunohistochemistry.
|